Overexpression of thymidylate synthase mediates desensitization for 5‐fluorouracil of tumor cells

The prognosis of cancers of various organs overexpressing thymidylate synthase (TS) has been reported to be poor. It has been suggested that the poor prognosis is partly due to a low sensitivity of TS-overexpressing tumors to TS-targeting 5-fluorouracil (5-FU). To investigate the relationship between TS expression and sensitivity to 5-FU, we used the TS-overexpressing cervical cancer cell line SKG-II/TS and SKG-I/TS that had been established by TS gene transfer. The 50% growth inhibitory concentration (IC50) of 5-FU for SKG-II/TS was 24 ± 6.0 μM, which was 6 times as high as that for the control (4.0 ± 1.1 μM), showing significantly decreased sensitivity to 5-FU (p < 0.01). The IC50 of 5-FU for SKG-I/TS was 90 ± 15 μM, which was over 2 times as high as that for the control (40 ± 0.6 μM), showing significantly decreased sensitivity to 5-FU (p < 0.05). Thus, TS-overexpressing tumors have decreased sensitivity to 5-FU, which may be one of the factors that determine the prognosis of these tumors. © 2003 Wiley-Liss, Inc.